Original paper Umbilical cord blood| Volume 17, ISSUE 7, P969-978, July 2015

Human allogeneic AB0/Rh-identical umbilical cord blood cells in the treatment of juvenile patients with cerebral palsy

Published:March 17, 2015DOI:


      Background aims

      The term “cerebral palsy” (CP) encompasses many syndromes that emerge from brain damage at early stages of ontogenesis and manifest as the inability to retain a normal body position or perform controlled movements. Existing methods of CP treatment, including various rehabilitation strategies and surgical and pharmacological interventions, are mostly palliative, and there is no specific therapy focused on restoring injured brain function.


      During a post-registration clinical investigation, the safety and efficacy of intravenous infusion of allogeneic human leukocyte antigen (HLA)-unmatched umbilical cord blood (UCB) cells were studied in 80 pediatric patients with cerebral palsy and associated neurological complications. Patients received up to 6 intravenous infusions of AB0/Rh-identical, red blood cell–depleted UCB cells at an average dose of 250 × 106 viable cells per infusion.


      Patients were followed for 3–36 months, and multiple cell infusions did not cause any adverse effects. In contrast, in most patients who received four or more UCB cell infusions, positive dynamics related to significant improvements in neurological status and/or cognitive functions were observed.


      The results confirm that multiple intravenous infusions of allogeneic AB0/Rh-identical UCB cells may be a safe and effective procedure and could be included in treatment and rehabilitation programs for juvenile patients with cerebral palsy.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Gluckman E.
        • Rosha V.
        Cord blood transplantation: state of the art.
        Haematologica. 2009; 94: 451-454
        • Gluckman E.
        Milestones in umbilical cord blood transplantation.
        Blood Rev. 2011; 25: 255-259
        • Zhao Y.
        • Wang H.
        • Mazzone T.
        Identification of stem cells from umbilical cord blood with embryonic and hematopoietic characteristics.
        Exp Cell Res. 2006; 312: 2454-2464
        • Kogler G.
        • Sensken S.
        • Airey J.A.
        • Trapp T.
        • Müschen M.
        • Feldhahn N.
        • et al.
        A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.
        J Exp Med. 2004; 200: 123-135
        • Hildbrand P.
        • Cirulli V.
        • Prinsen R.C.
        • Smith K.A.
        • Torbett B.E.
        • Salomon D.R.
        • et al.
        The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors.
        Blood. 2004; 104: 2010-2019
        • Kang X.Q.
        • Zang W.J.
        • Bao L.J.
        • Li D.L.
        • Xu X.L.
        • Yu X.J.
        • et al.
        Differentiating characterization of human umbilical cord blood-derived mesenchymal stem cells in vitro.
        Cell Biol Int. 2006; 30: 569-575
        • McGuckin C.P.
        • Forraz N.
        • Baradez M.O.
        Production of stem cells with embryonic characteristics from human umbilical cord blood.
        Cell Prolif. 2005; 38: 245-255
        • Hussan I.
        • Magd S.A.
        • Eremin O.
        • Eichler H.
        Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.
        Stem Cell. 2004; 22: 625-634
        • Borlongan C.V.
        • Hadman M.
        • Sanberg C.D.
        • Sanberg P.R.
        Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke.
        Stroke. 2004; 35: 2385-2389
        • Fan C.G.
        • Zhang Q.J.
        • Tang F.W.
        • Han Z.B.
        • Wang G.S.
        • Han Z.C.
        Human umbilical cord blood cells express neurotrophic factors.
        Neurosci Lett. 2005; 380: 322-325
        • Bae S.H.
        • Kong T.H.
        • Lee H.S.
        • Kim K.S.
        • Hong K.S.
        • Chopp M.
        • et al.
        Long-lasting paracrine effects of human cord blood cells (hUCBCs) on damaged neocortex in an animal model of cerebral palsy.
        Cell Transplant. 2012; 21: 2497-2515
        • Castillo-Melendez M.
        • Yawno T.
        • Jenkin G.
        • Miller S.L.
        Stem cell therapy to protect and repair the developing brain: a review of mechanisms of action of cord blood and amnion epithelial derived cells.
        Front Neurosci. 2013; 24: 194
        • Harris D.T.
        • Rogers I.
        Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine.
        Curr Stem Cell Res Ther. 2007; 2: 301-309
        • Reimann V.
        • Creutzig U.
        • Kogler G.
        Stem cells derived from cord blood in transplantation and regenerative medicine.
        Dtsch Arztebl Int. 2009; 106: 831-836
        • Prasad V.K.
        • Kurtzberg J.
        Umbilical cord blood transplantation for non-malignant diseases.
        Bone Marrow Transplant. 2009; 44: 643-665
        • Pimentel-Coelho P.M.
        • Mendez-Otero R.
        Cell therapy for neonatal hypoxic-ischemic encephalopathy.
        Stem Cells Dev. 2010; 19: 299-309
        • Ali H.
        • Bahbahani H.
        Umbilical cord blood stem cells—potential therapeutic tool for neural injuries and disorders.
        Acta Neurol Exp. 2010; 70: 316-324
        • Walker P.A.
        • Harting M.T.
        • Shah S.K.
        • Cox C.S.
        Progenitor cell therapy for the treatment of central nervous system injury: a review of the state and current clinical trials.
        Stem Cells Int. 2010; 2010: 369578
        • Arien-Zakay H.
        • Lecht S.
        • Nagler A.
        • Lazarovici P.
        Human umbilical cord blood stem cells: Rationale for use as a neuroprotectant in ischemic brain disease.
        Int J Mol Sci. 2010; 11: 3513-3528
        • Wang F.
        • Maeda N.
        • Yasuhara T.
        • Kameda M.
        • Tsuru E.
        • Yamashita T.
        • et al.
        The therapeutic potential of human umbilical cord blood transplantation for neonatal hypoxic-ischemic brain injury and ischemic stroke.
        Acta Med Okayama. 2012; 66: 429-434
        • Phillips A.W.
        • Johnston M.V.
        • Fatemi A.
        The potential for cell-based therapy in perinatal brain injuries.
        Transl Stroke Res. 2013; 4: 137-148
        • Rubinstein P.
        • Dobrila L.
        • Rosenfield R.E.
        • Adamson J.W.
        • Migliaccio G.
        • Migliaccio A.R.
        • et al.
        Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.
        Proc Natl Acad Sci USA. 1995; 92: 10119-10122
        • Sutherland D.R.
        • Anderson L.
        • Keeney M.
        • Nayar R.
        • Chin-Yee I.
        The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering.
        J Hematother. 1996; 5: 213-226
        • Pranke P.
        • Hendrikx J.
        • Alespeiti G.
        • Nadri N.
        • Rubinstein P.
        • Visser J.
        Comparative quantification of umbilical cord blood CD34+ and CD34+ bright cells using the ProcountTM-BD and ISHAGE protocols.
        Braz J Med Biol Res. 2006; 39: 901-906
        • Gregson J.M.
        • Leathley M.
        • Moore A.P.
        • Sharma A.K.
        • Smith T.L.
        • Watkins C.L.
        Reliability of the Tone Assessment Scale and the modified Ashworth scale as clinical tools for assessing poststroke spasticity.
        Arch Phys Med Rehabil. 1999; 80: 1013-1016
        • McPeak L.A.
        • Stiers W.M.
        • Cope D.N.
        Disability evaluation following traumatic brain injury.
        Phys Med Rehabil Clin N Am. 2001; 12: 587-601
      1. CanChild Centre for Childhood Disability Research. Gross Motor Function Classification System. [accessed 06.12.2014 ].

        • Halbrecht J.
        Fresh and stored placental blood.
        Lancet. 1939; 2: 1263
        • Hassall O.
        • Bedu-Addo G.
        • Adarkwa M.
        • Danso K.
        • Bates I.
        Umbilical cord blood transfusion in children with severe anaemia in under-resourced countries.
        Lancet. 2003; 361: 678-679
        • Bhattacharya N.
        Placental umbilical cord whole blood transfusion: a safe and genuine blood substitute for patients of the under-resourced world at emergency.
        J Am Coll Surg. 2005; 200: 557-563
        • Bhattacharya N.
        Placental umbilical cord blood transfusion: A novel method of treatment of patients with malaria in the background of anemia.
        Clin Exp Obstet Gynecol. 2006; 33: 39-43
        • Bhattacharya N.
        Placental umbilical cord whole blood transfusion to combat anemia in the background of tuberculosis and emaciation and its potential role as an immuno-adjuvant therapy for the under-resourced people of the world.
        Clin Exp Obstet Gynecol. 2006; 33: 99-104
        • Bhattacharya N.
        A preliminary report of 123 units of placental umbilical cord whole blood transfusion in HIV-positive patients with anemia and emaciation.
        Clin Exp Obstet Gynecol. 2006; 33: 117-121
        • Riordan N.H.
        • Chan C.
        • Marleau A.M.
        • Ichim T.E.
        Cord blood in regenerative medicine: do we need immune suppression?.
        J Transl Med. 2007; 5: 8
        • Sun J.
        • Allison J.
        • McLaughlin C.
        • Sledge L.
        • Waters-Pick B.
        • Wease S.
        • et al.
        Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurological disorders.
        Transfusion. 2010; 50: 1980-1987
        • Liao Y.
        • Cotten M.
        • Tan S.
        • Kurtzberg J.
        • Cairo M.S.
        Rescuing the neonatal brain from hypoxic injury with autologous cord blood.
        Bone Marrow Transplant. 2013; 48: 890-900
        • Lee Y.H.
        • Choi K.V.
        • Moon J.H.
        • Jun H.L.
        • Kang H.R.
        • Oh S.I.
        • et al.
        Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.
        J Transl Med. 2012; 10: 58
        • Yang W.Z.
        • Zhang Y.
        • Wu F.
        • Min W.P.
        • Minev B.
        • Zhang M.
        • et al.
        Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.
        J Transl Med. 2010; 8: 75
        • Yang W.Z.
        • Zhang Y.
        • Wu F.
        • Zhang M.
        • Cho S.C.
        • Li C.Z.
        • et al.
        Human umbilical cord blood-derived mononuclear cell transplantation: case series of 30 subjects with hereditary ataxia.
        J Transl Med. 2011; 9: 65
        • Min K.
        • Song J.
        • Kang J.Y.
        • Ko J.
        • Ryu J.S.
        • Kang M.S.
        • et al.
        Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.
        Stem Cells. 2013; 31: 581-591
        • Domanska-Janik K.
        • Buzanska L.
        • Lukomska B.
        A novel, neural potential of non-hematopoietic human umbilical cord blood stem cells.
        Int J Dev Biol. 2008; 52: 237-248
        • Bachstetter A.D.
        • Pabon M.M.
        • Cole M.J.
        • Hudson C.E.
        • Sanberg P.R.
        • Willing A.E.
        • et al.
        Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain.
        BMC Neurosci. 2008; 9: 22
        • Bae S.H.
        • Lee H.S.
        • Kang M.S.
        • Strupp B.J.
        • Chopp M.
        • Moon J.
        The levels of pro-inflammatory factors are significantly decreased in cerebral palsy patients following an allogeneic umbilical cord blood transplant.
        Int J Stem Cells. 2012; 5: 31-38
        • Cotten C.M.
        • Murtha A.P.
        • Goldberg R.N.
        • Grotegut C.A.
        • Smith B.S.
        • Goldstein R.F.
        • et al.
        Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy.
        J Pediatr. 2014; 164: 973-979